Sign in
4

Changes in Ownership

Definium Therapeutics, Inc. Filed Acc 0000950170-24-023201

Options or other derivatives

  • Chief Legal Officer acquired 125,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Sullivan Mark · Chief Legal Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-02-27 Grant or award : show line 1 in the form Stock Option (Right to Buy) +125,000 125,000 D
Loading xslF345X05/ownership.xml…